Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema

Published:2024-03-14 Issue: Volume: Page:22-27
ISSN:2397-6764
Container-title:European Medical Journal
language:
Short-container-title:EMJ

Author:

Cross Caroline E¹

Affiliation:

1. Reading, UK

Abstract

Modern targeted prophylaxis is recommended for patients with hereditary angioedema (HAE), but many remain on attenuated androgens. EMJ spoke to two HAE experts who explain how they help patients to make the switch.

Publisher

European Medical Group

Reference17 articles.

1. Maurer M et al. The international WAO/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update. Allergy. 2022;77(7):1961-90.

2. Santacroce R et al. The genetics of hereditary angioedema: a review. J Clin Med. 2021;10(9):2023.

3. Bork K et al. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008;100(2):153-61.

4. Bouillet L et al. Long-term prophylaxis in hereditary angioedema management: current practices in France and unmet needs. Allergy Asthma Proc. 2022;43(5):406-12.

5. Van der Poorten MM et al. Hereditary angioedema (HAE) in Belgium: results from a national survey. Front Allergy. 2023;4:1143897.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP